Kimbell Royalty Partners achieved record Q2 2026 results with daily production hitting 25,830 Boe/d and revenues reaching $103 million from oil, natural gas, and NGLs. Net income rose to approximately $47.3 million, supported by acquisitions and organic growth, while Adjusted EBITDA hit a record $84.9 million. The company increased its borrowing base from $625 million to $660 million and declared a 15% higher cash distribution of $0.47 per common unit, reflecting a 13% annualized yield. Kimbell plans to use 25% of its cash available for distribution to reduce debt and expects to update guidance following a recent acquisition closing.
Opus Genetics, a clinical-stage biotech focused on inherited retinal diseases, received a Buy rating and $8 price target from analyst Matthew Caufield in August 2026. The company plans to release topline Phase 1/2 data for its gene therapy OPGx-BEST1...
General Electric (GE) announced it will acquire Consolidated Precision Products (CPP) for $11.75 billion to enhance its aerospace casting production. This strategic move aims to strengthen GE's manufacturing capabilities and accelerate engine technol...
United Natural Foods, Inc. (UNFI) reported a Q4 adjusted EPS of $0.69, surpassing analyst expectations of $0.61, signaling strong profitability. However, revenue slightly missed estimates at $7.64 billion, down 0.7% from the previous year. Despite th...
Ionis Pharmaceuticals faced a setback when its experimental heart drug pelacarsen failed a Phase 3 trial to reduce cardiovascular events, causing an 8.6% stock drop. However, an analyst from Canaccord Genuity maintained a bullish $85 price target, im...
Casey's General Stores will release its Q3 2026 earnings on September 8 after market close, with analysts expecting an EPS of $6.78 and revenue of $5.56 billion. The company has a strong history of exceeding earnings estimates, with an average surpri...
